Patients with acute severe heart failure treated in the emergency department of Chuiyangliu Hospital from July 2019 to July 2020 were taken as the research subjects in this retrospective parallel controlled clinical study to compare the efficacy and prognosis between the standard western medicine treatment (control group: spironolactone+captopril) and integrated traditional Chinese and western medicine treatment (integrated group: spironolactone+captopril+Shengmai Decoction). The cardiac ejection function was measured by echocardiography. The results showed that the E/A and LVEF of the integrated group were higher than those of the control group, while the LVES and LVED were lower than those of the control group; the incidence of adverse reactions such as hypokalemia, cough, and hyperkalemia in the integrated group was lower than that in the control group; the QOL score in the integrated group was higher than that in the control group. This suggests that Shengmaiyin combined with western medicine has certain advantage in the treatment of acute severe heart failure, which can further improve cardiac function, enhance left ventricular ejection ability, reduce adverse reactions and improve the prognosis and quality of life of patients.

integrated traditional Chinese and western medicine  /  severe heart failure  /  emergent treatment  /  left ventricular ejection fraction  /  Shengmai Decoction  /  captopril  /  spironolactone